18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma

NCT01169350 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

NIH

Sponsor class

Stopped funding source ended earlier than anticipated

Conditions

Recurrent Adult Soft Tissue Sarcoma
Stage I Adult Soft Tissue Sarcoma
Stage II Adult Soft Tissue Sarcoma
Stage III Adult Soft Tissue Sarcoma
Stage IV Adult Soft Tissue Sarcoma

Interventions

RADIATION: fludeoxyglucose F 18
OTHER: 18F-fluoromisonidazole
PROCEDURE: positron emission tomography
PROCEDURE: computed tomography
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)